Table 4 Associations of kidney tests at medical facilities and health checkups with the incidence of end-stage kidney disease among propensity score-matched pairs.

From: Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study

  

Checkups

No kidney test and no checkupa

Men

Number

5332

5332

Observational period, year

5.0 (5.0–5.0)

5.0 (4.5–5.0)

Incidence of ESKD, n (%)

11 (0.2)

24 (0.5)

IR per 1000 PY (95% CI)

0.5 (0.3–0.8)

1.1 (0.7–1.6)

Unadjusted SHR (95% CI)

1.00 (reference)

2.30 (1.13–4.70)

Women

Number

7573

7573

Observational period, year

5.0 (5.0–5.0)

5.0 (5.0–5.0)

Incidence of ESKD, n (%)

6 (0.1)

9 (0.1)

IR per 1000 PY (95% CI)

0.2 (0.1–0.4)

0.3 (0.1–0.5)

Unadjusted SHR (95% CI)

1.00 (reference)

1.54 (0.55–4.33)

  1. CI, confidence interval; ESKD, end-stage kidney disease; IR, incidence rate; PY, person-years; SHR, subhazard ratio.
  2. aNo dipstick urinalysis and no serum creatinine measurement at medical facilities and no health checkup in the past year.